Get a glimpse into our company and investor data—powered by the PitchBook Platform
Operator of a biotechnology company intended to develop collagen therapeutics to address surgical needs. The company has developed an enviable proprietary technology that utilizes bacterial-derived proteins as a platform for designing collagens for biomedical needs, enabling medical practitioners to tailor therapeutics to specific clinical indications.
You’re viewing a free company profile from the PitchBook Platform. To explore ECM Biosurgery’s full profile, request a free trial.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Seed Round | 28-Mar-2016 | $275K | 00000 | In Progress | Pre-Clinical Trials | |
2. Accelerator/Incubator | 09-Mar-2015 | Completed | Pre-Clinical Trials | |||
1. Grant | 01-Jan-2015 | $195K | Completed | Pre-Clinical Trials |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
---|---|---|---|---|---|---|
TMC Innovation | Accelerator/Incubator | 000 0000 | 000000 0 | |||
U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 |
Name | Title | Board Seat |
Contact Info |
---|---|---|---|
David McQuillan Ph.D | Chief Executive Officer & Board Member | ||
Magnus Hook Ph.D | Co-Founder, President & Chairman | ||
Brooke Russell Ph.D | Co-Founder & Vice President |
Name | Representing | Role | Since | Contact Info |
---|---|---|---|---|
David McQuillan Ph.D | ECM Biosurgery | Chief Executive Officer & Board Member | 000 0000 | |
Jed Rogers | ECM Biosurgery | Board Member | 000 0000 | |
John Untereker | Self | Board Member | 000 0000 | |
Joseph Patti Ph.D | Self | Board Member | 000 0000 | |
Larry Lawson | Self | Board Member | 000 0000 |